We saw last week that sales of Bioeffective A 320 are not crash hot.
SLA chose not to register the product - just list it with Therapeutic Goods Administration (TGA). Mere listing means that they can't make any claims on the packet about what Bioeffective A 320 fixes, even though we know that Russian scientists have researched an extensive list of what it cures. You can read this on the SLA website.
If SLA had registered the product with the TGA then SLA could make claims on the packet.
In addition SLA has complicated matters, from the point of view of sales, by making the product "For Practitioner Dispensing Only." This seemingly unnecessary step means that the product can't be displayed in health food stores and supermarkets alongside Blackmore's and other health products. Display in supermarkets would surely enhance sales.
Yesterday I was in an Aldi store. There was a large bin overflowing with "Goanna Arthritis Cream". Not a self-important title. There is a crude picture of a goanna on the packet. The general appearance of the packet is like a Harvey Norman ad. Yet the product is registered with TGA (not merely listed), claims on the packet to relieve arthritis pain, and has the chance of selling like hot cakes because it is displayed in a supermarket.
Isn't this where Bioeffective A 320 should be?
I am wondering now whether SLA's marketing strategy is a result of their feeling too self-important about the product. Bioeffective A 320 is not a prescription drug. Why make it look like one?
SLA Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)